Literature DB >> 16586007

Long-lasting remission of pemphigus vulgaris treated with rituximab.

Maria Esposito, Elisabetta Capriotti, Alessandro Giunta, Luca Bianchi, Sergio Chimenti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16586007     DOI： 10.2340/00015555-0007

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  7 in total

1.  Rituximab: a review of dermatological applications.

Authors:  Jason J Emer; Wolinsky Claire
Journal:  J Clin Aesthet Dermatol       Date:  2009-05

Review 2.  Rituximab in treatment-resistant autoimmune blistering skin disorders.

Authors:  Enno Schmidt; Eva-Bettina Bröcker; Matthias Goebeler
Journal:  Clin Rev Allergy Immunol       Date:  2008-02       Impact factor: 8.667

3.  Immunocytometric Analysis of Oral Pemphigus vulgaris Patients after Treatment with Rituximab as Adjuvant.

Authors:  Giulio Fortuna; Elena Calabria; Massimo Aria; Amerigo Giudice; Michele Davide Mignogna
Journal:  Biomolecules       Date:  2021-11-04

Review 4.  Off-Label Uses of Rituximab in Dermatology.

Authors:  Connor Cole; Kyle T Amber
Journal:  Curr Dermatol Rep       Date:  2022-10-06

5.  Rituximab in the treatment of pemphigus vulgaris.

Authors:  Labib R Zakka; Shawn S Shetty; A Razzaque Ahmed
Journal:  Dermatol Ther (Heidelb)       Date:  2012-11-15

6.  Effectiveness and side effects of anti-CD20 therapy for autoantibody-mediated blistering skin diseases: A comprehensive survey of 71 consecutive patients from the Initial use to 2007.

Authors:  Jennifer D Peterson; Lawrence S Chan
Journal:  Ther Clin Risk Manag       Date:  2009-03-26       Impact factor: 2.423

Review 7.  Novel applications of Rituximab in dermatological disorders.

Authors:  Prasan R Bhandari; Varadraj V Pai
Journal:  Indian Dermatol Online J       Date:  2014-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.